The MISTRG6 humanized mouse model, which incorporates patient-derived hematopoietic stem and progenitor cells, achieves comprehensive genetic matching of the tumor microenvironment, enabling the simulation of innate and adaptive immune interactions, including VEGF-A expression [200]. Here, VEGFA is linked to neoplasm.